Psychopharmacotherapy during pregnancy and lactation. Part I: Pregnancy;Psychopharmakotherapie wahrend graviditat und laktation. Teil 1: Graviditat

Nervenarzt

Volumn 69, Issue 1, 1998, Pages 1-14

  Lanczik, M ^a   Knoche, M ^b   Fritze, J ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Westfalische Zentrum F Psychiat P   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Postpartum effects; Pregnancy; Psychotropic drugs; Teratogenicity

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENPERIDOL; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; DIAZEPAM; FLUPENTIXOL; FLUPHENAZINE; FLUSPIRILENE; HALOPERIDOL; LITHIUM; MELPERONE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PERPHENAZINE; PHENOTHIAZINE; PIMOZIDE; PIPAMPERONE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIOXANTHENE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; ZUCLOPENTHIXOL;

BREAST FEEDING; CONGENITAL MALFORMATION; DRUG MILK LEVEL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INFANTILE HYPOTONIA; LACTATION; MANIC DEPRESSIVE PSYCHOSIS; PREGNANCY; PRENATAL DRUG EXPOSURE; PSYCHOPHARMACOLOGY; REVIEW; SIDE EFFECT; TERATOGENICITY; WEANING; DRUG EFFECT; MENTAL DISEASE; NEWBORN; PREGNANCY COMPLICATION; PUERPERAL DISORDER; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; PUERPERAL DISORDERS; RISK FACTORS;

EID: 0031607225     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050232     Document Type: Review

References (89)

1. Ang MS, Thorp JA, Parisi VM (1990) Maternal lithium therapy and polyhydramnios. Obstet Gynecol 76:517-518
2. Ashton H (1991) Psychotropic-drug prescribing for women. Br J Psychiatry 158:30-35
3. Athinarayanan P, Pierog S, Nigam SK, Glass L (1976) Chlordiazepoxide withdrawal in the neonate. Am J Obstet Gynecol 124:212-213
4. Auerbach JG, Hans SL, Marcus J, Maeir S (1992) Maternal psychotropic medication and neonatal behavior. Neurotox Teratol 14:399-406
5. Barry WS, St Clair SM (1987) Exposure to benzodiazepines in utero. Letter. Lancet I:1436-1437
6. Besunder JB, Blumer JL (1990) Neonatal drug withdrawal syndromes. In: Koren G (ed) Maternal-fetal toxicology. Decker, New York Basel, pp 161-190
7. Bologa M, Koren G, McGuigan M, Rieder MJ (1990) Drugs and chemicals most commonly used by pregnant women. In: Koren G (ed) Maternal-fetal toxicology. Decker, New York Basel, pp 29-51
8. Bracken MS, Horford TR (1981) Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 58:336-344
9. Cohen LS, Rosenbaum JF, Heller VL (1988) Prescribing lithium for pregnant women. Am J Psychiatry 145:772-773
10. Cuniff CM, Sahn DJ, Reed KL, Chambers CC, Johnson KA, Jones KL (1989) Pregnancy outcome in women treated with lithium. Teratology 39:447-448
11. Cohen LS (1992) The use of psychotropic drugs during pregnancy and the puerperium. Curr Affective Illness 11:5-13
12. Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF (1994) Impact of pregnancy on panic disorder: a case series. J Clin Psychiatry 55:284-288
13. Cooper GL (1988) The safety of fluoxetine-an update. Br J Psychiatry 153 [Suppl]:77-86
14. Cree JE, Meyer J, Haily DM (1973) Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn. Br Med J 4:251-254
15. Dalessio DJ (1988) Seizure disorders and pregnancy. N Engl J Med 312:559-563
16. Dicke JM (1989) Teratology: principles and practice. Med Clin North Am 73:567-581
17. Donaldson GL, Bury RG (1982) Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy. Acta Paediatr Scand 71:335-338
18. Edlund MJ, Craig TJ (1984) Antipsychotic drug use and birth defects: an epidemiologic reassessment. Compr Psychiatry 25:32-37
19. Eggermont E (1973) Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet 2:680
20. Fisher B, Edgren BE, Mammel MC, Coleman JM (1985) Neonatal apnea associated with maternal clonazepam therapy. Obstet Gynecol 66:34-35
21. Frank E, Kupfer DJ, Jacob M, Blumenthal SJ, Jarrett DB (1987) Pregnancy-related affective episodes among women with recurrent depression. Am J Psychiatry 144:288-293
22. Frankenberg FR, Lipinski F (1983) Congenital malformations. N Engl J Med 309:311-12
23. Freeman R (1972) Correspondence: limb deformities: possible association with drugs. Med J Aust 1:606-607
24. Gillberg C (1977) "Floppy-infant syndrome" and maternal diazepam. Letter. Lancet II:244
25. Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI (1989) Prevalence rates and demographic characteristics associated with depression in pregnancy and postpartum. J Consult Clin Psychol 57:269-274
26. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Littleton, Ma, pp 336-337
27. Holmes LB, Harvey EA, Hayes AM (1990) The teratogenic effects of anticonvulsant monotherapy: phenobarbital (Pb), carbamazepine (CBZ) and phenytoin (PHT). Teratology 41:565
28. Hyman SE, Arana GW (1987) Handbook of psychiatric drug therapy. Little Brown, Boston
29. Jacobsen SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld AE, Rieder M, Santelli R, Smythe J, Pastuszak A, Einarson T, Koren G (1992) Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 2:530-533
30. Jick H (1988) Early pregnancy and benzodiazepines. J Clin Psychopharmacol 8:159-160
31. Jones KL, Lacro RV, Johnson KA, Adams J (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666
32. Kallen B, Tandberg A (1983) Lithium and pregnancy. A cohort study on manic depressive women. Acta Psychiatr Scand 68:134-139
33. Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychosis. Br J Psychiatry 150:662-673
34. Kopelman AE, McCullar FW, Heggeness L (1975) Limb malformations following maternal use of haloperidol. JAMA 231:62-64
35. Krause S, Ebbesen F, Lange AP (1990) Polyhydramnios with maternal lithium treatment. Obstet Gynecol 75:504-506
36. Lagreid L, Olegard R, Wahlstrom J, Conradi N (1987) Abnormalities in children exposed to benzodiazepines in utero. Lancet 1:108-109
37. Lammer EJ, Sever LE, Oakley GP (1987) Teratogen update: valproic acid. Teratology 35 465-473
38. Lier L, Kastrup M, Rafaelsen OJ (1989) Psychiatric illness in relation to childbirth and pregnancy, II: diagnostic profiles, psychosocial and perinatal aspects. Nord Psykiatr Tidsskr 43:535-542
39. MacKay AV, Loose R, Glen AI (1976) Labour on lithium. Letter. Br Med J 1:878
40. Mandrelli M, Morselli PL, Nordic S, Pardi G, Principi N, Sereni F, Tognoni G (1975) Placental transfer of diazepam and its deposition in the newborn. Clin Pharmacol Ther 17:564-572
41. Marchetti F, Romero M, Bonati M, Tognoni G (1993) Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Eur J Clin Pharmacol 45:495-501
42. McBride WM (1972) Limb deformities associated with iminodibenzyl hydrochloride. J Med Aust 59:492-493
43. Milkovich L, van den Berg BJ (1974) Effects of prenatal meprobamate and chlordiazepoxid hydrochloride on human embryonic and fetal development. N Engl J Med 291:1268-1271
44. Morell P, Sutherland GR, Buamah PK, Oo M, Bain HH (1983) Lithium toxicity in a neonate. Arch Dis Child 58:538-539
45. Mortola JF (1989) The use of psychotropic agents in pregnancy and lactation. Psychiatr Clin North Am 12:69-87
46. Nars PW, Girard J (1977) Lithium carbonate intake during pregnancy leading to large goiter in a premature infant. Am J Dis Child 131:924-925
47. Neziroglu F, Anemone R, Yaryura TJA (1992) Onset of obsessive compulsive disorder in pregnancy. Am J Psychiatry 149:947-950
48. Niebyl JR (1992) Drug therapy during pregnancy. Curr Opin Obstet Gynecol 4:43-47
49. Paffenbarger RS, McCabe LJ (1966) The effect of obstetric and perinatal events on risk of mental illness in women of childbearing age. Am J Public Health 56:400-407
50. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeid A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Hom M, Koren G (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269:2246-2248
51. Pork JM, Sridaromont S, Ledbetter BO, Terry WM (1980) Ebstein's anomaly of the tricuspid valve asociated with prenatal exposure to lithium carbonate. Am J Dis Child 134:703-704
52. Poulson E, Robson JM (1964) Effect of phenelzine and some related compounds on pregnancy. J Endocrinol 30 205-215
53. Rachelefsky GS, Flynt JW, Ebbin AJ (1972) Possible teratogenicity of tricyclic antidepressants. Lancet 1:838
54. Rayburn W, Wible-Kant J, Bledsoe J (1982) Changing trends in drug use during pregnancy. J Reprod Med 27:569-575
55. Rementeria JL, Batt K (1977) Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 90:123-126
56. Rieder RO, Rosenthal D, Wender P, Blumenthal H (1975) The offspring of schizophrenics. Fetal and neonatal deaths. Arch Gen Psychiatry 32:200-211
57. Robinson GE, Stewart DE, Flak E (1986) The rational of use of psychotropic drugs in pregnancy and postpartum. Can J Psychiatry 31:183-190
58. Rosa FW (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324:674-677
59. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louir C, Shapiro S (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309:1282-1285
60. Rumeau-Rouquette C, Goujard J, Huel G (1977) Possible teratogenic effects of phenotiazines in human beings. Teratology 15:57-64
61. Sandoz (1993) Annual Report 5:Melleril, pp 14-15
62. Schimell MS, Katz EZ, Shaag Y, Pastuszak A, Koren G (1991) Toxic neonatal effects following maternal domipramine therapy. Clin Toxicology 29:479-484
63. Schou M, Goldfield MD, Weinstein MR, Villeneuve A (1973) Lithium and pregnancy-I. Report from the register of lithium babies. Br Med J II:135-136
64. Shader RI (1992) Does continous use of fluoxetine during first trimester of pregnancy present a high risk for malformation or abnormal development to the exposed fetus? J Clin Pharmacol 12:441
65. Shatan C (1966) Withdrawal symptoms after abrupt termination of imipramine. Can Psychiatr Assoc J 11:150-158
66. Shearer WT, Schreiner RL, Marshall RE (1972) Urinary retention in a neonate secondary to maternal ingestion of nortryptiline. J Pediatr 81:570-572
67. Shiono PH, Mills JL (1984) Oral defts and diazepam use during pregnancy. Correspondence. N Engl Med J 311:919-920
68. Singh S, Gulati G, Narang A, Bhakoo ON (1990) Non-narcotic withdrawal syndrome in a neonate due to maternal clomiprarmine therapy. J Pediatr Child Health 26:110
69. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S (1977) Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight and intelligence quotient score. Am J Obstet Gynecol 128 486-488
70. St Clair SM, Schirmer RG (1992) First-trimester exposure to alprazolam. Obstet Gynecol 80:843-846
71. Stewart DE, Robinson GE (1993) Psychotropic drugs and electroconvulsive therapy during pregnancy and lactation. In: Stewart DE, Stotland NL (eds) Psychological aspects of women's health care. American Psychiatric Press Washington, pp 71-95
72. Stirrat GM, Beard RW (1973) Drugs to be avoided or given with caution in the second or third trimester of pregnancy. Prescribers J 13:135-140
73. Thiels C (1988) Neuroleptika in der Schwangerschaft und Stillzeit In: Helmchen H, Hippius H,Tolle R (Hrsg) Therapie mit Neuroleptika-Perazin. Thieme Stuttgart, S 97-100
74. Troyer WA, Pereira GR, Lannon RA, Belik J, Yoder MC (1993) Association of maternal lithium exposure and premature delivery. J Perinatology 13:123-127
75. Vemadakis A, Parker AA (1980) Drugs and the developing central nervous system. Pharmacol Ther 11 593-647
76. Vorhees CV, Butcher RE (1982) Behavioral teratogenicity. In: Snell K (ed) Developmental toxicology. Praeger New York, pp 249-298
77. Koren G (1992) Lithium and pregnancy. Lancet 339 (letter).869
78. Volpe JJ (1981) Teratogenic effects of drugs and passive addiction. In: Volpe JJ (ed) Neurology of the newborn. Saunders, Philadelphia, pp 601-635
79. van Waes A, van de Velde E (1969) Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol 9:224-227
80. Ware MR, de Vane CL (1990) Imipramine treatment of panic disorder during pregnancy. J Clin Psychiatr 51:482-484
81. Warkany J (1988) Teratogen update: lithium. Teratology 38:593-596
82. Weber LWD (1985) Benzodiazepines in pregnancy-academic debate or teratogenic risk? Biol Res Pregn 6:151-167
83. Webster PAC (1973) Withdrawal symptomes in neonates associated with maternal antidepressants therapy. Lancet 2:318-319
84. Weinstein MR, Goldfieid MD (1975) Cadiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132:529-531
85. Wilbanks GD, Bressler HC, Peete CH, Cherny WB, London WL (1970) Toxic effects of lithium carbonate in a mother and newborn infant. JAMA 213:865-867
86. Wilson N, Forfar JC, Godman MJ (1983) Atrial flutter in the newborn resulting from maternal lithium ingestion. Arch Dis Child 58:538-549
87. Yoder MC, Belik J, Lannon RA, Pereira GR (1984) Infants of mothers treated with lithium during pregnancy have an increased incidence of prematury, macrosomia, and perinatal mortality. Pediatr Res 18:163
88. Zalzstein E, Koren G, Einarson T, Freedom RM (1990) A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 65:817-818
89. Speight ANP (1977) Floppy infant syndrome and maternal diazepam and/or nitrazepam. Lancet II:878